H. Nakamura et al., IN-VITRO FORMATION, DISPOSITION AND TOXICITY OF N-ACETOXY-SULFAMETHOXAZOLE, A POTENTIAL MEDIATOR OF SULFAMETHOXAZOLE TOXICITY, The Journal of pharmacology and experimental therapeutics, 274(3), 1995, pp. 1099-1104
Variation in the formation and disposition of the hydroxylamine of (SM
X-HA) is thought to play an important role in the pathogenesis of sulf
amethoxazole(SMX)-induced idiosyncratic adverse drug reactions. We hyp
othesized that, in analogy to carcinogenic arylamines, SMX-HA might be
further converted to an electrophilic N-acetoxy metabolite which coul
d play a role in mediating SMX toxicity. Accordingly, we chemically sy
nthesized N-acetoxy-SMX, and examined the characteristics of its forma
tion, metabolism, cytotoxicity and mutagenicity in human and bacterial
test systems. The human arylamine N-acetyltransferases, (NAT)1 and NA
T2, were capable of converting SMX-HA to N-acetoxy-SMX. NAT1 and NAT2
possessed similar affinities for SMX-HA (apparent K-m values of 650 an
d 520 mu M, respectively), but the apparent maximal velocity of the NA
T1-mediated acetylation was higher than that of NAT2. (1332 vs. 37 nmo
l/min/U of immunoreactive NAT protein). Human peripheral blood mononuc
lear cells 12,000 x g supernatant fractions converted N-acetoxy-SMX ma
inly back to SMX-HA, and also to a lesser extent to SMX, at clinically
relevant concentrations. Similar pathways were observed in human hepa
tic cytosolic fractions. In a cytotoxicity assay, N-acetoxy-SMX was si
gnificantly more toxic to human peripheral blood mononuclear cells tha
n SMX-HA (16.6 vs. 11.5% dead cells at a concentration of 300 mu M). N
-acetoxy-SMX was weakly mutagenic to the Salmonella typhimurium TA100
strain in the Ames test. These data suggest that the N-acetoxy metabol
ites of sulfonamides could potentially play a role in mediating sulfon
amide idiosyncratic adverse drug reactions.